Decisive point for gensight in the short termSolid'action which is about to exceed probably € 10 in the short term if we go above € 9.35 at 11:45 am.
−0.5987USD
−28.94 MUSD
1.40 MUSD
53.95 M
About GENSIGHT BIOLOGICS SA
Sector
CEO
Laurence Rodriguez
Headquarters
Paris
Website
Employees (FY)
16
Founded
2012
ISIN
FR0013183985
FIGI
BBG00J6GYH38
GenSight Biologics SA is a clinical-stage gene therapy company, which engages in research and development of novel therapies for mitochondrial and neurodegenerative diseases of the eye. It also focuses on central nervous system diseases. The company was founded by Bernard Jacques Alex Gilly, Botond Roska, Jean Bennett, Connie Cepko, Luk H. Vandenberghe, Serge Picaud and Jose-Alain Sahel in 2012 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GSGTF is 0.4500 USD — it has decreased by 4.26% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange GENSIGHT BIOLOGICS SA stocks are traded under the ticker GSGTF.
GENSIGHT BIOLOGICS SA is going to release the next earnings report on Sep 23, 2024. Keep track of upcoming events with our Earnings Calendar.
GSGTF stock is 6.67% volatile and has beta coefficient of 0.50. Check out the list of the most volatile stocks — is GENSIGHT BIOLOGICS SA there?
Yes, you can track GENSIGHT BIOLOGICS SA financials in yearly and quarterly reports right on TradingView.
GSGTF net income for the last quarter is −15.72 M USD, while the quarter before that showed −13.05 M USD of net income which accounts for −20.45% change. Track more GENSIGHT BIOLOGICS SA financial stats to get the full picture.
Today GENSIGHT BIOLOGICS SA has the market capitalization of 33.99 M, it has increased by 14.82% over the last week.
No, GSGTF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GSGTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENSIGHT BIOLOGICS SA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 16.00 employees. See our rating of the largest employees — is GENSIGHT BIOLOGICS SA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENSIGHT BIOLOGICS SA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENSIGHT BIOLOGICS SA stock shows the sell signal. See more of GENSIGHT BIOLOGICS SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GENSIGHT BIOLOGICS SA future price: according to them, GSGTF price has a max estimate of 0.43 USD and a min estimate of 0.43 USD. Read a more detailed GENSIGHT BIOLOGICS SA forecast: see what analysts think of GENSIGHT BIOLOGICS SA and suggest that you do with its stocks.